Figure 3. Typical ROI placement in MS patients and healthy controls.
a) DAWM in MRIneg, b) NAWM in MRIneg, c) DAWM in MRIpos, d) NAWM in MRIpos, e) WM lesion in MRIpos, f) NWM in a healthy control. MRIneg subject was a 43 years old female, MRIpos subject was a 66 years old female and healthy subject was a 42 years old female.